跳至主要内容
临床试验/NCT00519961
NCT00519961Unknown不适用

A Prospective Study to Assess the Screening Value of N-terminal Pro-B-type Natriuretic Peptide (NT-proBNP) for the Identification of Patients That Benefit From Additional Cardiac Testing Prior to Vascular Surgery

Hoffmann-La Roche2 个研究点 分布在 2 个国家目标入组 1,800 人开始时间: 2007年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
1,800
试验地点
2
主要终点
Collection of 30-day and 1-year postoperative cardiac events

研究概览

简要总结

The purpose of this study is to validate the screening potential of NT-proBNP for the identification of patients scheduled for vascular surgery who would benefit from additional pre-operative cardiac testing. All patients will have NT-proBNP concentrations measured pre-operatively. For low-intermediate risk patients only those with abnormal values will receive further cardiac testing; all high risk patients will be referred for additional testing.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Adult patients, ≥18 years of age
  • •Patients with peripheral vascular atherosclerosis, scheduled for vascular surgery

排除标准

  • 未提供

研究组 & 干预措施

B

Experimental

干预措施: Elecsys®proBNP (Device)

A

Experimental

干预措施: Elecsys®proBNP (Device)

结局指标

主要结局

Collection of 30-day and 1-year postoperative cardiac events

时间窗: 30-day and 1-year postoperation

次要结局

未报告次要终点

研究者

申办方类型
Industry

研究点 (2)

Loading locations...

相似试验

A Prospective Study to Assess the Screening Value of... | 临床试验